Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Cancers|October 23, 2021
Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated RadiotherapyKuan-Cho Liao, Hui-Ching Chuang, Chih-Yen Chien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2012
Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeuticsChien-Feng Li, Ju-Ming Wang, Hong-Yo Kang, et al.
Histopathology|July 30, 2013
HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs)Yu-Ching Wei, Fong-Fu Chou, Chien-Feng Li, et al.
Annals of Surgical Oncology|July 16, 2011
EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impactChien-Feng Li, Fu-Ming Fang, Ju-Ming Wang, et al.
Journal of Clinical Pathology|January 24, 2012
Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicatorLi-Ching Wu, Li-Tzong Chen, Yueh-Ju Tsai, et al.
The Lancet. Oncology|January 30, 2017
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trialDenis Soulières, Sandrine Faivre, Ricard Mesía, et al.
Ecotoxicology and Environmental Safety|November 7, 2024
Effects of urinary organophosphate flame retardants in susceptibility to attention-deficit/hyperactivity disorder in school-age childrenLiang-Jen Wang, How-Ran Chao, Chih-Cheng Chen, et al.
Frontiers in Endocrinology|June 19, 2023
Urinary levels of organophosphate flame retardants metabolites in a young population from Southern Taiwan and potential health effectsFeng-Shun Chen, Chih-Cheng Chen, Ching-Chang Tsai, et al.
Lancet (London, England)|August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyJong-Mu Sun, Lin Shen, Manish A Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal CancerCaroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
Pageof 18